The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor

Sara Parsa1, Ana Ortega-Molina1, Hsia-Yuan Ying2

  • 1Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Nature Cancer
|February 11, 2021
PubMed

Insights

Amplification of serine hydroxymethyltransferase-2 (SHMT2) cooperates with BCL2 to initiate lymphoma. SHMT2 promotes epigenetic silencing of tumor suppressors, driving lymphomagenesis.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Epigenetics

Background:

  • Cancer cells exhibit altered metabolism for growth.
  • Metabolic enzyme activity is rarely considered a primary driver of cancer.
  • The role of serine hydroxymethyltransferase-2 (SHMT2) in lymphoma initiation is unexplored.

Purpose of the Study:

  • To investigate the role of SHMT2 in lymphoma initiation.
  • To understand the mechanism by which SHMT2 contributes to lymphomagenesis.

Main Methods:

  • Analysis of SHMT2 localization to chromosome 12q14.1 in lymphoma.
  • Investigating the cooperation between SHMT2 and BCL2 in lymphoma development.
  • Assessing the impact of SHMT2 loss or inhibition on lymphoma cell survival.
  • Examining SHMT2's role in DNA and histone methylation patterns.

Main Results:

  • SHMT2 is located at chromosome 12q14.1, a region with frequent copy number gains in lymphoma.
  • Elevated SHMT2 expression collaborates with BCL2 to promote lymphoma.
  • SHMT2 inhibition or loss reduces lymphoma cell survival.
  • SHMT2 alters DNA and histone methylation, silencing tumor suppressor genes like SASH1 and PTPRM.

Conclusions:

  • SHMT2 amplification, in conjunction with BCL2, is sufficient for initiating lymphomagenesis.
  • SHMT2 drives lymphoma initiation by epigenetically silencing tumor suppressor genes.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K